Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

The effects of facilitated percutaeous coronary intervention compared to primary percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction

Trial Profile

The effects of facilitated percutaeous coronary intervention compared to primary percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction

Completed
Phase of Trial: Phase IV

Latest Information Update: 13 Mar 2008

At a glance

  • Drugs Tirofiban (Primary) ; Aspirin; Clopidogrel; Heparin
  • Indications Embolism and thrombosis; Myocardial infarction
  • Focus Therapeutic Use
  • Most Recent Events

    • 13 Mar 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top